Certara (NASDAQ:CERT) Trading 6.1% Higher – Here’s Why

Shares of Certara, Inc. (NASDAQ:CERT) were up 6.1% on Friday . The company traded as high as $7.27 and last traded at $7.2140. Approximately 2,622,633 shares traded hands during trading, an increase of 1% from the average daily volume of 2,590,531 shares. The stock had previously closed at $6.80.

Key Headlines Impacting Certara

Here are the key news stories impacting Certara this week:

• Positive Sentiment: FY‑2025 results showed 9% revenue growth to $418.8M, adjusted EBITDA up 10% to $134.5M, and Q4 software revenue +10% — evidence of recovering commercial momentum in the higher‑margin software business. Certara Reports Fourth Quarter 2025 Financial Results
• Positive Sentiment: New CEO Jon Resnick is executing an operational overhaul with plans for sharper strategic focus and ~ $10M of cost avoidance — a management change investors often view as constructive for execution and long‑term growth. CEO signals operational overhaul
• Positive Sentiment: Barclays maintained an Overweight stance on CERT (despite lowering its price target), indicating some sell‑side support for the name even after recent guidance/earnings. Barclays price target change
• Neutral Sentiment: Management will participate in upcoming investor conferences — a chance to press the case for the turnaround and provide more color to investors. Investor conference participation
• Neutral Sentiment: Broker and media earnings breakdowns are circulating (useful for detail on items behind adjusted metrics and bookings vs. revenue). Earnings breakdown
• Negative Sentiment: GAAP and adjusted metrics disappointed in places: Q4 adjusted diluted EPS of $0.09 (down vs. prior year) and a GAAP net loss; management guided FY‑2026 revenue of only 0–4% (and set revenue range below Street expectations), which pressured near‑term growth expectations. Guidance and Q4 results
• Negative Sentiment: Craig Hallum downgraded CERT from Buy to Hold, reflecting analyst caution after the quarter and guidance; such downgrades can increase selling pressure. Analyst downgrade (Craig Hallum)

Wall Street Analyst Weigh In

A number of brokerages have recently commented on CERT. Leerink Partners reissued an “outperform” rating and issued a $10.00 target price on shares of Certara in a research note on Thursday. KeyCorp cut their price objective on Certara from $13.00 to $12.00 and set an “overweight” rating on the stock in a research report on Thursday, January 8th. Stephens reduced their price objective on Certara from $15.00 to $12.00 and set an “overweight” rating on the stock in a research note on Friday, December 12th. TD Cowen reiterated a “buy” rating on shares of Certara in a research note on Thursday. Finally, BMO Capital Markets initiated coverage on Certara in a report on Thursday, November 13th. They set a “market perform” rating and a $9.00 target price on the stock. One analyst has rated the stock with a Strong Buy rating, six have issued a Buy rating, six have issued a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $11.10.

Certara Stock Up 4.1%

The company has a market capitalization of $1.13 billion, a price-to-earnings ratio of -708.00 and a beta of 1.47. The company has a quick ratio of 2.09, a current ratio of 2.09 and a debt-to-equity ratio of 0.27. The firm has a 50 day moving average price of $8.36 and a two-hundred day moving average price of $9.89.

Certara (NASDAQ:CERT) last issued its quarterly earnings results on Thursday, February 26th. The company reported $0.09 EPS for the quarter, missing analysts’ consensus estimates of $0.11 by ($0.02). Certara had a negative net margin of 0.38% and a positive return on equity of 4.19%. The business had revenue of $103.65 million during the quarter, compared to analysts’ expectations of $103.23 million. During the same period in the prior year, the company posted $0.15 EPS. The company’s revenue for the quarter was up 3.2% on a year-over-year basis. Certara has set its FY 2026 guidance at 0.440-0.480 EPS. As a group, sell-side analysts expect that Certara, Inc. will post 0.28 earnings per share for the current year.

Institutional Inflows and Outflows

Several hedge funds have recently added to or reduced their stakes in the stock. Northwestern Mutual Wealth Management Co. raised its stake in shares of Certara by 2,733.3% in the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 2,975 shares of the company’s stock valued at $26,000 after purchasing an additional 2,870 shares in the last quarter. First Horizon Corp bought a new stake in Certara in the third quarter valued at about $30,000. Versant Capital Management Inc raised its stake in Certara by 66.7% during the third quarter. Versant Capital Management Inc now owns 2,881 shares of the company’s stock valued at $35,000 after buying an additional 1,153 shares in the last quarter. Osaic Holdings Inc. raised its stake in Certara by 50.7% during the second quarter. Osaic Holdings Inc. now owns 3,491 shares of the company’s stock valued at $41,000 after buying an additional 1,175 shares in the last quarter. Finally, Elevation Point Wealth Partners LLC bought a new position in Certara during the 2nd quarter worth approximately $59,000. 73.96% of the stock is owned by institutional investors and hedge funds.

About Certara

Certara is a biosimulation software and services company that partners with pharmaceutical, biotechnology and medical device developers to accelerate drug discovery, development and regulatory approval. The company’s platform integrates quantitative pharmacology, real-world evidence, artificial intelligence and machine learning to model and simulate drug behavior across a range of therapeutic areas and patient populations. By applying these mechanistic and data-driven approaches, Certara helps its clients predict clinical outcomes, optimize dosing strategies and streamline decision-making throughout the product lifecycle.

The company’s offerings are divided into software tools and consulting services.